Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.

Arch Virol

Division of Molecular Neurobiology, Institute for Enzyme Research (KOSOKEN), Tokushima University, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.

Published: July 2017

The N-terminal polybasic region of the normal prion protein, PrP, which encompasses residues 23-31, is important for prion pathogenesis by affecting conversion of PrP into the pathogenic isoform, PrP. We previously reported transgenic mice expressing PrP with residues 25-50 deleted in the PrP-null background, designated as Tg(PrP∆preOR)/Prnp mice. Here, we produced two new lines of Tg(PrP∆preOR)/Prnp mice, each expressing the mutant protein, PrP∆preOR, 1.1 and 1.6 times more than PrP in wild-type mice, and subsequently intracerebrally inoculated RML and 22L prions into them. The lower expresser showed slightly reduced susceptibility to RML prions but not to 22L prions. The higher expresser exhibited enhanced susceptibility to both prions. No prion transmission barrier was created in Tg(PrP∆preOR)/Prnp mice against full-length PrP. PrP∆preOR accumulated in the brains of infected Tg(PrP∆preOR)/Prnp mice less than PrP in control wild-type mice, although lower in RML-infected Tg(PrP∆preOR)/Prnp mice than in 22L-infected mice. Prion infectivity in infected Tg(PrP∆preOR)/Prnp mice was also lower than that in wild-type mice. These results indicate that deletion of residues 25-50 only slightly affects prion susceptibility, the conversion of PrP into PrP, and prion infectivity in a strain-specific way. PrP∆preOR retains residues 23-24 and lacks residues 25-31 in the polybasic region. It is thus conceivable that residues 23-24 rather than 25-31 are important for the polybasic region to support prion pathogenesis. However, other investigators have reported that residues 27-31 not 23-24 are important to support prion pathogenesis. Taken together, the polybasic region might support prion pathogenesis through multiple sites including residues 23-24 and 27-31.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00705-017-3295-3DOI Listing

Publication Analysis

Top Keywords

tgprp∆preor/prnp mice
24
prion pathogenesis
20
polybasic region
16
residues 25-50
12
mice
12
wild-type mice
12
residues 23-24
12
support prion
12
prion
10
residues
9

Similar Publications

Parkinson's disease (PD) is an age-related neurodegenerative pathology of the central nervous system. The well-known abnormalities characteristic of PD are dysfunctions in the nigrostriatal system including the substantia nigra of the midbrain and the striatum. Moreover, in PD persons, alpha-synucleinopathy is associated with abnormalities in the dopaminergic brain system.

View Article and Find Full Text PDF

Transmissible Spongiform Encephalopathies are fatal neurodegenerative diseases caused by the misfolding of the cellular prion protein (PrP) into its pathological isoform (PrP). Efficient transmission of PrP occurs within the same species, but a species barrier limits interspecies transmission. While PrP structure is largely conserved among mammals, variations at the β2-α2 loop are observed, and even minor changes in the amino acid sequence of the β2-α2 loop can significantly affect transmission efficiency.

View Article and Find Full Text PDF

The cellular prion protein (PrP) plays many roles in the developing and adult brain. In addition, PrP binds to several amyloids in oligomeric and prefibrillar forms and may act as a putative receptor of abnormal misfolded protein species. The role of PrP in tau seeding and spreading is not known.

View Article and Find Full Text PDF

Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivo.

Alzheimers Dement

October 2024

Department of Neurology, University Medical Center and the German Center for Neurodegenerative Diseases (DZNE), Georg-August University, Goettingen, Germany.

Introduction: Cellular prion protein (PrP) was implicated in amyloid beta (Aβ)-induced toxicity in Alzheimer's disease (AD), but the precise molecular mechanisms involved in this process are unclear.

Methods: Double transgenic mice were generated by crossing Prnp knockout (KO) with 5xFAD mice, and light-sheet microscopy was used for whole brain tissue analyses. PrP-overexpressing cells were developed for in vitro studies, and microscopy was used to assess co-localization of proteins of interest.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!